18 Stocks Moving In Monday's Pre-Market Session

Gainers

• Corbus Pharmaceuticals Holdings Inc CRBP rose 87.2 percent to $10.95 in the pre-market trading after the company reported positive topline results from Phase 2 study evaluating Resunab for the treatment of diffuse cutaneous systemic sclerosis.
• Eleven Biotherapeutics Inc EBIO rose 27.9 percent to $3.35 in pre-market trading. Eleven Biotherapeutics posted Q3 earnings of $0.91 per diluted share on revenue of $28.65 million.
• Amaya Inc. AYA shares rose 25 percent to $17.00 in pre-market trading. Amaya posted upbeat Q3 earnings and issued a strong FY16 earnings forecast. Amaya’s former CEO, David Baazov, offered to acquire the company in a deal valued at around C$3.48 billion, or $2.56 billion.
• Harman International Industries Inc HAR shares rose 24.9 percent to $109.45 in pre-market trading after Samsung Electronics announced plans to buy the company in an $8 billion deal.
• Digi International Inc. DGII rose 22.8 percent to $14.30 in pre-market trading. Belden Inc. BDC proposed to buy Digi International for $13.82 per share. However, Digi International’s board confirmed the rejection of proposal from Belden.
• Mentor Graphics Corp MENT rose 19.4 percent to $36.64 in pre-market trading after Siemens announced plans to acquire the company for $37.25 per share in cash.
• Tuniu Corp TOUR rose 13.7 percent to $9.90 in pre-market trading after gaining 0.35 percent on Friday.
• Ocular Therapeutix Inc OCUL shares rose 13.5 percent to $7.80 in pre-market trading after the company reported successful topline results for both inflammation and pain primary efficacy endpoints from its Phase 3 clinical trial of DEXTENZA.
• Mechel PAO (ADR) MTL shares rose 13.4 percent to $6.18 in pre-market trading after dropping 3.20 percent on Friday
• Archer Daniels Midland Company ADM rose 8.9 percent to $45.45 in the pre-market trading session after dropping 7.64 percent on Friday.
• PTC Therapeutics, Inc. PTCT rose 8 percent to $12.20 in pre-market trading. Credit Suisse upgraded PTC Therapeutics from Neutral to Outperform and raised the price target from $15.00 to $25.00.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

• Dynavax Technologies Corporation DVAX shares fell 71.1 percent to $3.35 in pre-market trading following announcement of a Complete Response Letter from the FDA.
• Resource Capital Corp. RSO shares fell 26.2 percent to $8.98 in pre-market trading. Resource Capital reported Q3 funds from operations of $12.9 million, or $42 per share.
• Galena Biopharma Inc GALE fell 14.1 percent to $3.61 in pre-market trading after the company disclosed that data from GALE-301/GALE-302 clinical program was presented at the Society for Immunotherapy of Cancer Conference 2016.
• Central European Media Enterprises Ltd. CETV shares fell 5.8 percent to $2.45 in the pre-market trading session after gaining 4.00 percent on Monday.
• Aecom ACM fell 5.3 percent to $30.50 in pre-market trading after the company posted downbeat Q4 results.
• Petroleo Brasileiro SA Petrobras (ADR) PBR fell 5.1 percent to $9.23 in pre-market trading after dropping 5.90 percent on Friday.
• Concordia International Corp CXRX shares fell 4.6 percent to $2.70 in pre-market trading after surging 25.78 percent on Friday.